Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Oraglobulin Aktiebolag
AB
Active
Org 5564668225
Finnboda Kajväg 8, 131 72
Nacka
Activities of advertising agencies
· NACE 7311
Est. 1993
0 employees
Watchlist
Share
Sweden
/
Companies
/
Activities of advertising agencies
/
Oraglobulin Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
1M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
1M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
1 226
167
233
148
Staff expenses
—
—
—
—
−41
EBITDA
−4
1 182
35
118
−13
Depreciation & amort.
−0
−0
−0
−0
—
EBIT
−4
1 182
35
118
−13
Net financials
—
—
1
30
28
Profit before tax
−4
1 182
36
148
15
Tax
−0
−247
−17
−37
−11
Net profit
−4
935
19
111
3
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
471
1 696
1 578
1 518
1 523
Equity
335
1 269
1 289
1 400
1 403
Long-term debt
0
0
0
0
—
Short-term debt
137
427
289
119
120
Total debt
137
427
289
119
120
Financial ratios
5-year trend
EBITDA margin
-8.8%
This company
15.8%
Market median
-156% vs market
2020
2024
Equity ratio
92.1%
This company
38.2%
Market median
+141% vs market
2020
2024
Return on equity
0.2%
This company
18.4%
Market median
-99% vs market
2020
2024
Net profit margin
2.3%
This company
8.1%
Market median
-72% vs market
2020
2024
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
2020
2024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Oraglobulin Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
